Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hauschke

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
International Journal of Clinical Pharmacology, Therapy, and Toxicology|December 1, 1992
Effect of changing the bioequivalence range from (0.80, 1.20) to (0.80, 1.25) on the power and sample sizeV W Steinijans, W W Hauck, E Diletti, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 30, 2001
Dose linearity and steady state pharmacokinetics of the new antiparkinson agent budipine after oral administrationT H Bethke, M Merz, K Zech, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 23, 2016
Telemedically Supported Case Management of Living-Donor Renal Transplant Recipients to Optimize Routine Evidence-Based Aftercare: A Single-Center Randomized Controlled TrialA Schmid, S Hils, A Kramer-Zucker, et al.
Journal of Biopharmaceutical Statistics|March 1, 1997
Choice of student's t- or Wilcoxon-based confidence intervals for assessment of average bioequivalenceW W Hauck, D Hauschke, E Diletti, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 1, 1994
Presentation of the intrasubject coefficient of variation for sample size planning in bioequivalence studiesD Hauschke, W V Steinijans, E Diletti, et al.
British Journal of Anaesthesia|June 3, 2017
Oesophageal Doppler guided goal-directed haemodynamic therapy in thoracic surgery - a single centre randomized parallel-arm trialK B Kaufmann, L Stein, L Bogatyreva, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 1, 1995
Reference tables for the intrasubject coefficient of variation in bioequivalence studiesV W Steinijans, R Sauter, D Hauschke, et al.
Der Pathologe|November 8, 2013
[Differential diagnosis of myeloproliferative neoplasms. Quantitative NF-E2 immunohistochemistry for differentiating between essential thrombocythemia and primary myelofibrosis]K Aumann, A-V Frey, A M May, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 21, 2006
Roflumilast, a once-daily oral phosphodiesterase 4 inhibitor, lacks relevant pharmacokinetic interactions with inhaled salbutamol when co-administered in healthy subjectsT D Bethke, T Giessmann, K Westphal, et al.
Neuromuscular Disorders : NMD|December 5, 2013
Somatropin treatment of spinal muscular atrophy: a placebo-controlled, double-blind crossover pilot studyJ Kirschner, D Schorling, D Hauschke, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
International Journal of Clinical Pharmacology, Therapy, and Toxicology|December 1, 1992
Effect of changing the bioequivalence range from (0.80, 1.20) to (0.80, 1.25) on the power and sample sizeV W Steinijans, W W Hauck, E Diletti, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 30, 2001
Dose linearity and steady state pharmacokinetics of the new antiparkinson agent budipine after oral administrationT H Bethke, M Merz, K Zech, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 23, 2016
Telemedically Supported Case Management of Living-Donor Renal Transplant Recipients to Optimize Routine Evidence-Based Aftercare: A Single-Center Randomized Controlled TrialA Schmid, S Hils, A Kramer-Zucker, et al.
Journal of Biopharmaceutical Statistics|March 1, 1997
Choice of student's t- or Wilcoxon-based confidence intervals for assessment of average bioequivalenceW W Hauck, D Hauschke, E Diletti, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 1, 1994
Presentation of the intrasubject coefficient of variation for sample size planning in bioequivalence studiesD Hauschke, W V Steinijans, E Diletti, et al.
British Journal of Anaesthesia|June 3, 2017
Oesophageal Doppler guided goal-directed haemodynamic therapy in thoracic surgery - a single centre randomized parallel-arm trialK B Kaufmann, L Stein, L Bogatyreva, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 1, 1995
Reference tables for the intrasubject coefficient of variation in bioequivalence studiesV W Steinijans, R Sauter, D Hauschke, et al.
Der Pathologe|November 8, 2013
[Differential diagnosis of myeloproliferative neoplasms. Quantitative NF-E2 immunohistochemistry for differentiating between essential thrombocythemia and primary myelofibrosis]K Aumann, A-V Frey, A M May, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 21, 2006
Roflumilast, a once-daily oral phosphodiesterase 4 inhibitor, lacks relevant pharmacokinetic interactions with inhaled salbutamol when co-administered in healthy subjectsT D Bethke, T Giessmann, K Westphal, et al.
Neuromuscular Disorders : NMD|December 5, 2013
Somatropin treatment of spinal muscular atrophy: a placebo-controlled, double-blind crossover pilot studyJ Kirschner, D Schorling, D Hauschke, et al.
Pageof 5